
11.25 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 6.29 Today|||52-Week Range 21.70 | +70.45% Year-to-Date |
Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance Nov 22 / Zacks.com - Paid Partner Content |
Previous close | 10.66 |
Today’s open | 10.70 |
Day’s range | 10.59 - 11.28 |
Volume | 5,954 |
Average volume (3 months) | 174,155 |
Market cap | $277.2M |
Earnings growth (last year) | +9.02% |
Earnings growth (this year) | -28.94% |
Earnings growth (next 5 years) | +25.77% |
Revenue growth (last year) | +17.75% |
P/E ratio | NM |
Price/Sales | 4.79 |
Price/Book | 3.16 |
Today’s change | Today’s % change | |
---|---|---|
BNGOBionano Genomics Inc | +0.06 | +4.09% |
AFFYAffymax Inc | 0.00 | 0.00% |
KZRKezar Life Sciences ... | +0.00 | +0.29% |
--Zero Gravity Solutio... | 0.00 | 0.00% |
Next reporting date | February 22, 2024 |
EPS forecast (this quarter) | -$0.24 |
Annual revenue (last year) | $34.4M |
Annual profit (last year) | -$26.7M |
Net profit margin | -77.47% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Valencia, California |